UK healthcare cost agency rejects J&J's nasal spray for depression

Britain's healthcare cost agency on Tuesday recommended against including Johnson & Johnson's nasal spray for depression, Spravato, in the country's healthcare network, citing uncertainties over its clinical and cost effectiveness.

from Reuters: Company News https://ift.tt/36zUPgq